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ABSTRACT 
The big health threats are detected by Public Health indicators through surveillance systems, worldwide and/or at the 
European and/or Spanish levels. Solid and hematologic neoplasia’s, cardiovascular and respiratory diseases, chronic and 
aging related diseases, infectious diseases, among others, are the main health problems; in the under-developed countries, 
problems arisen from lower socio-sanitary conditions may magnify the effects of severe and other moderate diseases.  
 
At the clinical setting, the health workers, physicians and nurses detect unresolved problems in the prevention, diagnosis, 
support, care and treatment of diseases, when attending different patients. Depending on the presence or the absence of 
underlying debilitating and chronic conditions, the clinical manifestations and the outcomes of the diseases, in terms of 
disability or death, are different and evolving in time. Currently, important technological improvements, including new drugs 
and devices, new types of surgery, or new diagnosis methods, as examples, have permitted better management of many 
diseases. However, new challenges continuously appeared, depending on new diseases or old non-resolved problems, 
despite the previous advances or, in the field of the infectious diseases, because the ability to recognize old pathogens, the 
emergence of new virus, and the worldwide emergence of the multidrug- and extensively-drug-resistance to antimicrobials in 
bacteria. 
 
Clinicians must be involved in the formulation of hypothesis to look for new solutions in the management of the old and 
emergent health problems and diseases, to improve the care and the cure of the patients and to prevent diseases. Clinical 
research is the classical approach to answer the questions derived from those hypotheses and to achieve new knowledges, 
which can be applied directly in the attention to the patients. However, many questions need a clinical/experimental approach 
to obtain useful results and, consequently, a multidisciplinary team, including biologists, biotechnologists, chemists, engineers 
and physicians, among others, is needed. The Sanitary Research Institutes were configured in 2004 through the cooperation 
between Hospitals and Universities, to have the framework where a very close multidisciplinary work can be developed. 
However, we must have an open mind to efficiently collaborate with any scientific, in any institution, in any company, in any 
country, in the context of an open scientific world. . 
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